This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both an aminopiperidine moiety and a ketone group, makes it a valuable building block for developing compounds with potential therapeutic effects. It is often employed in the creation of drugs targeting neurological disorders, including pain management and psychiatric conditions, due to its ability to interact with specific receptors in the central nervous system. Additionally, its chemical properties make it suitable for further modifications, enabling the development of novel drug candidates with enhanced efficacy and selectivity.